Offsetting the Biotech Firms' Good News
There is no doubt that good news is filling the media about outperformances of both development-stage small biotech firms and revenues-generating firms. This good news has been offset by inflation, hiked interest rates, that aimed at bringing down the inflation, the continued presence of COVID-19 and an unwarranted European  war, which has only demonstrated the terrible impact on the world’s economy on life. 

We posted articles and press releases about the biotech and biopharma firms' scientific outperformances and will continue to post the same about our picked firms during this . . .